📰 **Intellia Therapeutics, Inc. (NTLA) Discusses Topline Phase 3 HAELO Trial Results for Lonvoguran Ziclumeran in Hereditary Angioedema - Slideshow**

🔗 https://seekingalpha.com/article/4894721-intellia-therapeutics-inc-ntla-discusses-topline-phase-3-haelo-trial-results-for-lonvoguran?source=feed_all_articles

#markets #news